Fifth Third Bancorp Alkermes Plc. Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Alkermes Plc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,116 shares of ALKS stock, worth $29,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,116
Previous 1,479
24.54%
Holding current value
$29,607
Previous $48,000
35.42%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
407Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$772 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$483 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$313 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$213 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$183 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.36B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...